A PYMNTS Company

The EC Pharmaceutical Inquiry: Behind the Headlines, What is the Real Story on Innovation and Generic Competition in Pharmaceuticals?

BY | November 11, 2008

This article is part of a Chronicle. See more from this Chronicle Thomas Cueni, Nov 12, 2008 While the pharmaceutical sector waits for the European Commission’s interim report and hearing…

This article is part of a Chronicle. See more from this Chronicle

Thomas Cueni, Nov 12, 2008

While the pharmaceutical sector waits for the European Commission’s interim report and hearing scheduled for November 28, 2008, there is an opportunity to step back and examine critically the premise of the inquiry started infamously with dawn raids on January 16, 2008 that, as Commissioner Kroes announced, “if innovative products are not being produced, and cheaper generic alternatives delay

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 142.93.75.231

Please verify email or join us to access premium content!